Kristie Blum

10PUBLICATIONS
62CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Neurology and neuromuscular diseasesImmunogenetics (incl. genetic immunology)Disease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 24, 2024
Impact of imaging frequency on progression-free survival in Alliance trials enrolling patients with follicular lymphoma.

Sarah C Rutherford, Jun Yin, Levi D Pederson

|Oct 21, 2022
Positron Emission Tomography-Adapted Therapy in Bulky Stage I/II Classic Hodgkin Lymphoma: CALGB 50801 (Alliance).

Ann S LaCasce, Travis Dockter, Amy S Ruppert

|Jul 05, 2022
Relevance of Bone Marrow Biopsies for Response Assessment in US National Cancer Institute National Clinical Trials Network Follicular Lymphoma Clinical Trials.

Sarah C Rutherford, Jun Yin, Levi Pederson

|May 02, 2022
End of induction positron emission tomography complete response (PET-CR) as a surrogate for progression-free survival in previously untreated follicular lymphoma.

Jesse G Dixon, Natalie Dimier, Tina Nielsen

|Apr 18, 2022
Humoral Responses Against SARS-CoV-2 and Variants of Concern After mRNA Vaccines in Patients With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia.

Andres Chang, Akil Akhtar, Susanne L Linderman

|Jan 27, 2021
Burkitt Lymphoma International Prognostic Index.

Adam J Olszewski, Lasse H Jakobsen, Graham P Collins

Pageof 2

Frequent Collaborators

2 joint publications

Jonathon B Cohen

2 joint publications

Nancy L Bartlett

2 joint publications

Bruce D Cheson

2 joint publications

Travis Dockter